← 產業報告目錄
Molecular Pharming Market Size, Share & Trends Analysis Report By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By Crop Source, By End User, By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 180報告編號 INSIGHTACE-27ae85ecfb
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 1655.3 Mn as of 2023, the global Molecular Pharming Market is anticipated to climb to USD 3516.73 Mn by 2034, reflecting a compound annual growth rate of 8.1% over the 2025–2034 period.
The Molecular Pharming sector involves genetically altered to create proteins and chemicals for industrial and pharmaceutical uses. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is fueled by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Pharming Market Snapshot
Chapter 4. Global Molecular Pharming Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Gene Gun
5.2.2. Agroinfiltration
5.2.3. Electroporation
5.2.4. Agrobacterium-Mediated Gene Transfer
5.2.5. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Recombinant Antibodies
6.2.2. Hormones
6.2.3. Vaccines
6.2.4. Industrial Enzymes
6.2.5. Proteins & Protein-Based Materials
6.2.6. Technical Reagents
6.2.7. Nutritional Products
6.2.8. Others
Chapter 7. Market Segmentation 3: by Crop Source Estimates & Trend Analysis
7.1. by Crop Source & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Crop Source:
7.2.1. Maize
7.2.2. Barley
7.2.3. Tobacco
7.2.4. Safflower
7.2.5. Rice
7.2.6. Alfalfa
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
8.2.1. Biotechnology & Pharmaceutical Companies
8.2.2. Contract Manufacturing Organizations
8.2.3. Others
Chapter 9. Molecular Pharming Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.1.2. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.3. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.1.4. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.1.5. North America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.2. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.3. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.2.4. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.2.5. Europe Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.2. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.3. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.3.4. Asia-Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3.5. Asia Pacific Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.2. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.3. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.4.4. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4.5. Latin America Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.2. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.3. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by Crop Source, 2021-2034
9.5.4. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5.5. Middle East & Africa Molecular Pharming Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Agrenvec S.L
10.2.2. Bright Biotech
10.2.3. Core Biogenesis
10.2.4. Diamante SRL
10.2.5. Leaf Systems International Limited
10.2.6. Medicago Inc
10.2.7. Meristem Therapeutics S.A. (Ventria Bioscience)
10.2.8. Miruku
10.2.9. Moolec Science Limited
10.2.10. mozza
10.2.11. Nobell Foods
10.2.12. ORF Genetics
10.2.13. Pfizer, Inc.
10.2.14. ProdiGene Inc
10.2.15. Protalix Biotherapeutics, Inc
10.2.16. Tiamat Sciences
10.2.17. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們